前收市價 | 12.78 |
開市 | 13.17 |
買盤 | 0.00 x 3100 |
賣出價 | 0.00 x 3200 |
今日波幅 | 12.51 - 13.01 |
52 週波幅 | 7.09 - 14.47 |
成交量 | |
平均成交量 | 10,487,179 |
市值 | 14.566B |
Beta 值 (5 年,每月) | 1.06 |
市盈率 (最近 12 個月) | 無 |
每股盈利 (最近 12 個月) | -0.50 |
業績公佈日 | 無 |
遠期股息及收益率 | 無 (無) |
除息日 | 2017年11月27日 |
1 年預測目標價 | 15.50 |
Teva, Dr. Reddy's and Viatris have been highlighted in this Industry Outlook article.
The impact of macroeconomic headwinds on the Zacks Medical - Generic Drugs industry is gradually improving. New product launches provide some respite to RDY, TEVA and VTRS.
A relatively modest amount of money can go a long way when it's put to work in top-tier businesses with abundant catalysts.